tirzepatide phase 2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type diabetes (SURPASS-3): a randomised, open-label, parallel-group, 3 trial Nexa Med Spa | Medical

17 evaluated the efficacy of polyamines at varying concentrations4 mM spermidine, 6 mM putrescine, and 6 mM spermineapplied as pulse treatments to maintain the postharvest quality of cut Consolida ajacis flowers

Hydrazone linker Hydrazone, an acid-labile group, is used as a cleavable linker that releases free drug through hydrolysis once an ADC is transported to acidic endosomes (pH 5.06.0) and lysosomes (pH about 4.8) (Fig

No explanation for medication changes Adjustments alone support 99214, yet many notes fail to explain the clinical reason behind those changes

A third approach works to improve gut health and boost GLP-1 production through the gut microbiome and short-chain fatty acids (SCFAs)

CrossRef Reshaping the Future of MASLD - From Pathophysiological Mechanisms to New Therapeutic Horizons Dimitrios Patoulias, Manfredi Rizzo Current Pharmaceutical Design .2026